Hmm… You finally got the name with which you have been struggling all these days and it’s called DIRA, a rare immune-related disease which most people have never heard of in the past. The moment you are still stuck at understanding this four letter word, Anakinra enters the picture. A lot of questions start popping up in your mind regarding its aspects. It feels stressful, right? but let your negative thoughts take a back seat because we will simplify these complex details, including what patients and caregivers should know about Anakinra Injection in India.
DIRA: What lies behind the name?
Deficiency of interleukin-1 receptor antagonist (DIRA) is a rare, life-threatening autoinflammatory disease that affects children. The body’s immune system works in such a way that it attacks your own body instead of attacking the infections.
DIRA is caused by mutations, or changes, that have occurred in a baby’s genes before birth.
Its symptoms usually begin within the first 8 weeks after a baby is born. These symptoms can include swelling of bone tissue, bone pain and deformity, skin rash that can cover most of the body, and elevated C-Reactive Protein levels.
It is difficult to diagnose this disease as doctors come across these atypical cases very rarely.
What is its therapeutic approach?
DIRA can be treated with Anakinra (Kineret) which blocks the activity of interleukin-1 (IL-1), a protein in the body that causes inflammation. This can help relieve painful and sometimes life-threatening symptoms.
For additional information about Anakinra in India, including pricing, import guidelines and access considerations, see our guide on Anakinra (Kineret) in India: Pricing, Import Guidelines & Access.
Dosage guidelines
The recommended starting dose of Anakinra is 1-2 mg/kg subcutaneously daily for patients with DIRA. The dose can be individually adjusted to a maximum of 8 mg/kg daily to control active inflammation. Physicians should consider administration of its prescribed dose every other day for patients with DIRA who have severe renal insufficiency or end stage renal disease (defined as creatinine clearance < 30 mL/min, as estimated from serum creatinine levels).
The prescribed strength and presentation are important when arranging treatment. For patients who have been prescribed the 100 mg presentation, information about Buy Anakinra Injection 100 mg in India should be considered according to the treating physician’s prescription.
For further information about Kineret uses and administration, see Kineret (Anakinra) in India: Uses, Administration & Where to Buy.
Avoid Anakinra:
If you are allergic to proteins made from bacteria called E. coli. Anakinra or any of the ingredients in Kineret.
Before starting Anakinra therapy, tell your healthcare provider if you:
- Have an infection, a history of infections that keep coming back, or other problems that can increase your risk of infections
- Are scheduled to receive any vaccines. People using Anakinra should not receive live vaccines
- Have kidney problems
- Are pregnant or plan to become pregnant. It is not known if Anakinra will harm your unborn baby
- Are breastfeeding or plan to breast feed. It is not known if Anakinra passes into your breast milk. You and your healthcare provider should decide if you will use Anakinra or breastfeed.
Side-effects
- The most common side-effects of patients receiving Anakinra are upper respiratory tract infections, rash, pyrexia, influenza like illness, and gastroenteritis.
Precautionary measures
- The risk of a disease flare when discontinuing Anakinra treatment should be weighed against the potential risk of continued treatment in Anakinra-treated DIRA patients. Do not initiate KINERET in patients with active infections.
- Use in combination with Tumor Necrosis Factor (TNF) blocking agents is not recommended
- Hypersensitivity reactions, including anaphylactic reactions and angioedema, and serious cutaneous reactions including Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) can occur; discontinue Anakinra, treat promptly, and monitor until reaction resolves. Patients with DIRA may have an increased risk of allergic reactions, particularly in the first several weeks after starting the therapy.
- The impact of treatment with Anakinra on active and/or chronic infections and the development of malignancies is not known.
- Live vaccines should not be given concurrently with Anakinra.
- Neutrophil counts should be assessed prior to initiating Anakinra treatment, and while receiving Anakinra, monthly for 3 months, and thereafter quarterly for a period up to 1 year.
When exploring access to Anakinra, factors such as the prescribed strength, product presentation, quantity and sourcing requirements can influence the anakinra injection price in india. Patients should also consider the specific formulation and presentation prescribed by their healthcare provider when checking the applicable cost.
For patients requiring the 100 mg presentation, the Anakinra Injection 100 mg price in India should be confirmed based on the specific product and current availability rather than relying on a general estimate. You can also refer to our Anakinra Injection in India: Pricing & Supplier Guide for further information.
Where Anakinra has been prescribed and needs to be obtained through an appropriate access pathway, patients and caregivers can explore information about how to Access Anakinra in India, including the applicable prescription and regulatory requirements.
For patients prescribed Kineret, information related to Buy Anakinra (Kineret) Injection in India should also be considered in accordance with the prescription and appropriate access requirements. For additional information about monitoring treatment, see Tracking Anakinra: How to Monitor Treatment, Absorption & Response.
Anakinra is not just about controlling the symptoms, but also maintains the treatment as safe as possible. Looking for a patient-friendly therapeutic guide? Explore our latest blogs and discover solutions designed around your needs at 24/7qualityMeds.
